{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T02:13:18Z","timestamp":1788401598869,"version":"build-2803163510"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014101","name":"Novavax Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014101","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.vaccine.2026.128208","type":"journal-article","created":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T17:00:24Z","timestamp":1768582824000},"page":"128208","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Immunogenicity and safety of a recombinant spike protein COVID vaccine in patients with inflammatory bowel disease and transplant recipient"],"prefix":"10.1016","volume":"75","author":[{"given":"Ahamed Lazim","family":"Vattoth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary S.","family":"Hayney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir Masoud","family":"Forati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandy","family":"Warren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raj","family":"Kalkeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miranda R.","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaohui","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MingZhu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shane","family":"Cloney-Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce S.","family":"Plested","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandesh","family":"Parajuli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Freddy","family":"Caldera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.vaccine.2026.128208_bb0005","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.cgh.2024.12.011","article-title":"AGA clinical practice update on noncolorectal Cancer screening and vaccinations in patients with inflammatory bowel disease: expert review","volume":"23","author":"Caldera","year":"2025","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"10","key":"10.1016\/j.vaccine.2026.128208_bb0010","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1001\/jama.2023.28019","article-title":"Prevalence of immunosuppression among US adults","volume":"331","author":"Martinson","year":"2024","journal-title":"JAMA"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2026.128208_bb0015","doi-asserted-by":"crossref","first-page":"A15","DOI":"10.1016\/j.vaccine.2020.11.037","article-title":"Influenza vaccination in immunocompromised populations: strategies to improve immunogenicity","volume":"39","author":"Caldera","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128208_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2025.126777","article-title":"Efficacy, immunogenicity, and safety of the Novavax COVID-19 vaccine in immunocompromised patients: a targeted literature review","volume":"49","author":"Gschwend","year":"2025","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128208_bb0025","doi-asserted-by":"crossref","first-page":"e630","DOI":"10.1093\/cid\/ciac103","article-title":"Prospective evaluation of coronavirus disease 2019 (COVID-19) vaccine responses across a broad Spectrum of immunocompromising conditions: the COVID-19 vaccination in the immunocompromised study (COVICS)","volume":"75","author":"Haidar","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2026.128208_bb0030","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2021-068632","article-title":"Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis","volume":"376","author":"Lee","year":"2022","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128208_bb0035","doi-asserted-by":"crossref","first-page":"176","DOI":"10.14309\/ajg.0000000000001570","article-title":"Humoral immunogenicity of mRNA COVID-19 vaccines among patients with inflammatory bowel disease and healthy controls","volume":"117","author":"Caldera","year":"2022","journal-title":"Am J Gastroenterol"},{"issue":"8","key":"10.1016\/j.vaccine.2026.128208_bb0040","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.3390\/v14081822","article-title":"A systematic review and Meta-analysis of serologic response following coronavirus disease 2019 (COVID-19) vaccination in solid organ transplant recipients","volume":"14","author":"Sakuraba","year":"2022","journal-title":"Viruses"},{"issue":"13","key":"10.1016\/j.vaccine.2026.128208_bb0045","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1056\/NEJMc2111462","article-title":"Randomized trial of a third dose of mRNA-1273 vaccine in transplant recipients","volume":"385","author":"Hall","year":"2021","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.vaccine.2026.128208_bb0050","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1093\/ibd\/izac082","article-title":"Humoral immunogenicity of 3 COVID-19 messenger RNA vaccine doses in patients with inflammatory bowel disease","volume":"28","author":"Schell","year":"2022","journal-title":"Inflamm Bowel Dis"},{"issue":"37","key":"10.1016\/j.vaccine.2026.128208_bb0055","doi-asserted-by":"crossref","first-page":"819","DOI":"10.15585\/mmwr.mm7337e2","article-title":"Use of COVID-19 vaccines for persons aged \u22656 months: recommendations of the advisory committee on immunization practices \u2014 United States, 2024\u20132025","volume":"73","author":"Panagiotakopoulos","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2026.128208_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcv.2022.105321","article-title":"NVX-CoV2373-induced cellular and humoral immunity towards parental SARS-CoV-2 and VOCs compared to BNT162b2 and mRNA-1273-regimens","volume":"157","author":"Hielscher","year":"2022","journal-title":"J Clin Virol"},{"issue":"6","key":"10.1016\/j.vaccine.2026.128208_bb0065","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1056\/NEJMoa2116185","article-title":"Efficacy and safety of NVX-CoV2373 in adults in the United States and Mexico","volume":"386","author":"Dunkle","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2026.128208_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2025.127046","article-title":"Immunogenicity and safety of a monovalent Omicron XBB.1.5 SARS-CoV-2 recombinant spike protein vaccine in previously unvaccinated, SARS-CoV-2 seropositive participants: Primary day-28 analysis of a phase 2\/3 open-label study","volume":"55","author":"Alves","year":"2025","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2026.128208_bb0075","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.3390\/microorganisms12061201","article-title":"Validation of a Pseudovirus neutralization assay for severe acute respiratory syndrome coronavirus 2: a high-throughput method for the evaluation of vaccine immunogenicity","volume":"12","author":"Cai","year":"2024","journal-title":"Microorganisms"},{"issue":"8","key":"10.1016\/j.vaccine.2026.128208_bb0080","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1093\/ibd\/izac193","article-title":"Higher cell-mediated immune responses in patients with inflammatory bowel disease on anti-TNF therapy after COVID-19 vaccination","volume":"29","author":"Caldera","year":"2023","journal-title":"Inflamm Bowel Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2026.128208_bb0085","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000688","article-title":"Higher and sustained cell-mediated immune responses after 3 doses of mRNA COVID-19 vaccine in patients with inflammatory bowel disease on anti-tumor necrosis factor therapy","volume":"15","author":"Caldera","year":"2024","journal-title":"Clin Transl Gastroenterol"},{"issue":"12","key":"10.1016\/j.vaccine.2026.128208_bb0090","doi-asserted-by":"crossref","first-page":"5746","DOI":"10.1002\/jmv.28055","article-title":"Humoral responses after inactivated COVID-19 vaccination in individuals with and without prior SARS-CoV-2 infection: a prospective cohort study","volume":"94","author":"Jia","year":"2022","journal-title":"J Med Virol"},{"issue":"5","key":"10.1016\/j.vaccine.2026.128208_bb0095","doi-asserted-by":"crossref","first-page":"e309","DOI":"10.1016\/S2352-3018(22)00041-8","article-title":"Immunogenicity and safety of a SARS-CoV-2 recombinant spike protein nanoparticle vaccine in people living with and without HIV-1 infection: a randomised, controlled, phase 2A\/2B trial","volume":"9","author":"Madhi","year":"2022","journal-title":"The lancet HIV"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128208_bb0100","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2024.2425147","volume":"20","author":"Shinde","year":"2024","journal-title":"Hum Vaccin Immunother"},{"issue":"4","key":"10.1016\/j.vaccine.2026.128208_bb0105","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/s00415-025-12991-8","article-title":"Evaluation of the efficacy of the SARS-CoV-2 vaccine additional and booster doses in immunocompromised patients with multiple sclerosis: the COVACiMS study","volume":"272","author":"Ladeira","year":"2025","journal-title":"J Neurol"},{"issue":"6","key":"10.1016\/j.vaccine.2026.128208_bb0110","doi-asserted-by":"crossref","first-page":"e339","DOI":"10.1016\/S2665-9913(24)00065-1","article-title":"Immunogenicity of third dose COVID-19 vaccine strategies in patients who are immunocompromised with suboptimal immunity following two doses (OCTAVE-DUO): an open-label, multicentre, randomised, controlled, phase 3 trial","volume":"6","author":"Goodyear","year":"2024","journal-title":"The Lancet Rheumatol"},{"issue":"6","key":"10.1016\/j.vaccine.2026.128208_bb0115","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1093\/ndt\/gfad010","article-title":"Serological response to Nuvaxovid (NVX-CoV2373) vaccine given as a fifth dose in non- and low-responder kidney transplant recipients","volume":"38","author":"Nowak","year":"2023","journal-title":"Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association"},{"key":"10.1016\/j.vaccine.2026.128208_bb0120","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1081933","article-title":"NVX-CoV2373-induced T- and B-cellular immunity in immunosuppressed people with multiple sclerosis that failed to respond to mRNA and viral vector SARS-CoV-2 vaccines","volume":"14","author":"Mueller-Enz","year":"2023","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2026.128208_bb0125","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1053\/j.gastro.2021.10.029","article-title":"Lower serologic response to COVID-19 mRNA vaccine in patients with inflammatory bowel diseases treated with anti-TNF\u03b1","volume":"162","author":"Edelman-Klapper","year":"2022","journal-title":"Gastroenterology"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26000150?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26000150?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T15:48:20Z","timestamp":1772552900000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26000150"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":25,"alternative-id":["S0264410X26000150"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128208","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunogenicity and safety of a recombinant spike protein COVID vaccine in patients with inflammatory bowel disease and transplant recipient","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128208","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"128208"}}